These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29875771)

  • 1. CH2 Domain of Mouse IgG3 Governs Antibody Oligomerization, Increases Functional Affinity to Multivalent Antigens and Enhances Hemagglutination.
    Klaus T; Bereta J
    Front Immunol; 2018; 9():1096. PubMed ID: 29875771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural difference in the complement activation site of human IgG1 and IgG3.
    Michaelsen TE; Sandlie I; Bratlie DB; Sandin RH; Ihle O
    Scand J Immunol; 2009 Dec; 70(6):553-64. PubMed ID: 19906198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysine 322 in the human IgG3 C(H)2 domain is crucial for antibody dependent complement activation.
    Thommesen JE; Michaelsen TE; Løset GÅ; Sandlie I; Brekke OH
    Mol Immunol; 2000 Nov; 37(16):995-1004. PubMed ID: 11395138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG subclass and heavy chain domains contribute to binding and protection by mAbs to the poly γ-D-glutamic acid capsular antigen of Bacillus anthracis.
    Hovenden M; Hubbard MA; Aucoin DP; Thorkildson P; Reed DE; Welch WH; Lyons CR; Lovchik JA; Kozel TR
    PLoS Pathog; 2013; 9(4):e1003306. PubMed ID: 23637599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agglutinating mouse IgG3 compares favourably with IgMs in typing of the blood group B antigen: Functionality and stability studies.
    Klaus T; Bzowska M; Kulesza M; Kabat AM; Jemioła-Rzemińska M; Czaplicki D; Makuch K; Jucha J; Karabasz A; Bereta J
    Sci Rep; 2016 Aug; 6():30938. PubMed ID: 27484487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylation is influential in murine IgG3 self-association.
    Panka DJ
    Mol Immunol; 1997 Jun; 34(8-9):593-8. PubMed ID: 9393962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable domain-identical antibodies exhibit IgG subclass-related differences in affinity and kinetic constants as determined by surface plasmon resonance.
    Cooper LJ; Robertson D; Granzow R; Greenspan NS
    Mol Immunol; 1994 Jun; 31(8):577-84. PubMed ID: 7515151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Basis of Assembly and Activation of Complement Component C1 in Complex with Immunoglobulin G1 and Antigen.
    Wang G; de Jong RN; van den Bremer ET; Beurskens FJ; Labrijn AF; Ugurlar D; Gros P; Schuurman J; Parren PW; Heck AJ
    Mol Cell; 2016 Jul; 63(1):135-45. PubMed ID: 27320199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid differences in the N-terminus of C(H)2 influence the relative abilities of IgG2 and IgG3 to activate complement.
    Sensel MG; Kane LM; Morrison SL
    Mol Immunol; 1997 Oct; 34(14):1019-29. PubMed ID: 9488053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region.
    Canfield SM; Morrison SL
    J Exp Med; 1991 Jun; 173(6):1483-91. PubMed ID: 1827828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.
    Liu F; Bergami PL; Duval M; Kuhrt D; Posner M; Cavacini L
    AIDS Res Hum Retroviruses; 2003 Jul; 19(7):597-607. PubMed ID: 12908937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differential ability of human IgG1 and IgG4 to activate complement is determined by the COOH-terminal sequence of the CH2 domain.
    Tao MH; Canfield SM; Morrison SL
    J Exp Med; 1991 Apr; 173(4):1025-8. PubMed ID: 2007852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding.
    Morgan A; Jones ND; Nesbitt AM; Chaplin L; Bodmer MW; Emtage JS
    Immunology; 1995 Oct; 86(2):319-24. PubMed ID: 7490135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human IgG4: a structural perspective.
    Davies AM; Sutton BJ
    Immunol Rev; 2015 Nov; 268(1):139-59. PubMed ID: 26497518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of synergistic complement-mediated lysis of rat red cells by monoclonal IgG antibodies.
    Hughes-Jones NC; Gorick BD; Howard JC
    Eur J Immunol; 1983 Aug; 13(8):635-41. PubMed ID: 6603980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.
    Bindon CI; Hale G; Brüggemann M; Waldmann H
    J Exp Med; 1988 Jul; 168(1):127-42. PubMed ID: 3260935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human IgG subclass pattern of inducing complement-mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentration.
    Michaelsen TE; Garred P; Aase A
    Eur J Immunol; 1991 Jan; 21(1):11-6. PubMed ID: 1703960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor targeting IgG3 triggers complement-mediated lysis of decay-accelerating factor expressing tumor cells through the alternative pathway amplification loop.
    Rösner T; Lohse S; Peipp M; Valerius T; Derer S
    J Immunol; 2014 Aug; 193(3):1485-95. PubMed ID: 24973443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens.
    Dhein J; Daniel PT; Trauth BC; Oehm A; Möller P; Krammer PH
    J Immunol; 1992 Nov; 149(10):3166-73. PubMed ID: 1431095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of complement by human IgG1 and human IgG3 antibodies against the human leucocyte antigen CD52.
    Redpath S; Michaelsen T; Sandlie I; Clark MR
    Immunology; 1998 Apr; 93(4):595-600. PubMed ID: 9659234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.